2019
DOI: 10.4040/jkan.2019.49.4.375
|View full text |Cite
|
Sign up to set email alerts
|

A Structural Model for Chemotherapy Related Cognitive Impairment and Quality of Life in Breast Cancer Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 31 publications
0
6
1
Order By: Relevance
“…More specifically, the proportion of patients indicating moderate-to-severe depression requiring medication rose from 11.6% before chemotherapy to 23.5% during chemotherapy. Such a level of depression is greater than that of 17.2% reported by Korean breast cancer patients suffering from moderate-to-severe depression in another study that used the same measurement tool as the current study (Lee, 2016), but is less than the 32.0% reported in another study on colorectal patients receiving chemotherapy (Baek and Yi, 2015) and 30.0% reported by yet another study (Oh and Lim, 2017). Viewing depression in cancer patients as behavioral side effects from the cancer diagnosis itself and treatment on the disease, the severity of depression experienced by cancer patients is thought to increase when they experience various chemotherapy-related side effects.…”
Section: Discussioncontrasting
confidence: 71%
“…More specifically, the proportion of patients indicating moderate-to-severe depression requiring medication rose from 11.6% before chemotherapy to 23.5% during chemotherapy. Such a level of depression is greater than that of 17.2% reported by Korean breast cancer patients suffering from moderate-to-severe depression in another study that used the same measurement tool as the current study (Lee, 2016), but is less than the 32.0% reported in another study on colorectal patients receiving chemotherapy (Baek and Yi, 2015) and 30.0% reported by yet another study (Oh and Lim, 2017). Viewing depression in cancer patients as behavioral side effects from the cancer diagnosis itself and treatment on the disease, the severity of depression experienced by cancer patients is thought to increase when they experience various chemotherapy-related side effects.…”
Section: Discussioncontrasting
confidence: 71%
“…In the present study, the cortical thickness of the medial frontal cortex and insular regions showed positive correlations, and the CSF volume of the third ventricle was negatively correlated with the degree of tumor differentiation in the chemotherapy group. It may be that the worse the tumor differentiation and the longer the average chemotherapy cycles, the more serious the damage to the medial prefrontal lobe and insular regions, and the greater the amount of CSF in the third ventricle ( 50 , 51 ). This situation was slightly different in the paired groups, mainly because the volumes of multiple brain regions distributed in the frontal, parietal, and occipital lobes were positively correlated with the duration after chemotherapy, except that the volume of the planum temporale was positively correlated with the differentiation degree of the tumor in the paired groups.…”
Section: Discussionmentioning
confidence: 99%
“…Depression was a significant factor contributing to "extreme memory problems". In a previous study by Lee [12], depression was found to be a factor that lowered the cognitive functions of patients with breast cancer undergoing chemotherapy. Additionally, there is a significant association between depression and low cognitive function in cross-country comparative studies [27].…”
Section: Journal Of Health Informatics and Statisticsmentioning
confidence: 89%